Abstract:A 71-year-old woman was admitted for a month of right lower abdominal pain and moderate jaundice. Serologic examinations revealed elevated total bilirubin (65.5 μmol/L), cancer antigen 19-9 (206.8 U/mL), carcinoembryonic antigen (4.05 ng/mL) and cancer antigen 125 (98.7 U/mL). Enhanced magnetic resonance imaging (MRI) revealed a patchy abnormal signal measuring about 3.2×3 cm2 in the right hepatic lobe and hepatic duct confluence and dilated intrahepatic bile ducts (Fig. 1). Intrahepatic cholangiocarcinoma involving the hepatic hilum was considered. The patient underwent a radical surgery. The resected specimen showed a solid tumor measuring 3×3.2×3 cm3, with the main body of the tumor located inside the liver. Postoperative pathology clarified the diagnosis of hepatic mixed neuroendocrinenon-neuroendocrine neoplasm (MiNEN) composed of a grade 3 (G3) neuroendocrine tumor (50%) (Fig.2, circled in yellow, H&E staining, 40x) and moderately differentiated adenocarcinoma (50%) (Fig. 2, circled in red, H&E staining, 40x). Immunohistochemical staining demonstrated that the tumor was positive for phosphoenolpyruvate carboxykinase (PCK), cytokeratin (CK)7, CK19, chromogranin A (CgA) (Fig. 3, 40x), mucin-1 (MUC-1) and synaptophysin (SYN), Ki-67 proliferation index 40% and mitotic index of 40/10 high power fields. Synaptophysin and CgA are both important immunohistochemical markers of neuroendocrine differentiation. Meanwhile, expression of CK7, CK19 and MUC-1 confirmed that the adenocarcinoma component originated from the intrahepatic bile duct epithelium. No other primary lesions were identified in the imaging studies. The patient was discharged on the 11th day postoperatively. She remains alive and continues being followed up at our hospital every 3 months. MiNEN, previously called mixed adeno-neuroendocrine carcinomas, are unusual, their diagnosis being challenging [1]. MiNENs are newly defined as composite neoplasms comprising non-neuroendocrine components and neuroendocrine components, each of which accounts for at least 30% [2]. The occurrence of MiNENs in the hepatobiliary system is extremely rare [3, 4]. The lack of typical clinical symptoms, laboratory and radiological features, makes the preoperative diagnosis difficult and furthermore leads to poor prognosis. Curative resection remains the primary treatment of MiNENs [5]. Meanwhile, definite diagnosis rely on the postoperative pathological examination.

Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?

Mixed Neuroendocrine Non-Neuroendocrine Tumor (MINEN) of the Liver: Report of Two Cases and Review of the Literature

Mixed neuroendocrine nonneuroendocrine neoplasms of the pancreas: a case report and literature review of pancreatic mixed neuroendocrine nonneuroendocrine neoplasm

Mixed neuroendocrine non-neuroendocrine neoplasms in gastroenteropancreatic tract

Mixed pancreatic ductal adenocarcinoma and well-differentiated neuroendocrine tumor: A case report

Clinicopathological Features and Lymph Node and Distant Metastasis Patterns in Patients with Gastroenteropancreatic Mixed Neuroendocrine‐non‐neuroendocrine Neoplasm

[The Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms].

Primary Hepatic Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm.

Gastric mixed neuroendocrine non-neuroendocrine neoplasms

Ampullary mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) is an exceptionally rare case presenting as abdominal pain

Nonfunctional neuroendocrine tumor of the pancreas: Case report and review of the literature

Minimal Invasive Surgery in the Treatment of Neuroendocrine Tumors of the Pancreas

Metastatic Mixed Acinar‐neuroendocrine Carcinoma of the Pancreas Treated by a Multidisciplinary Team: A Case Report and Brief Review of the Literature

Long-term Survival of Gastric Mixed Neuroendocrine-Non-neuroendocrine Neoplasm: Two Case Reports.

Mixed Neuroendocrine-Nonneuroendocrine Neoplasm of the Ampulla: Four Case Reports

Clinicopathological Features and Lymph Node Metastatic Patterns of Gastric Mixed Adenoneuroendocrine Carcinoma.

The Clinical Profiles, Management, and Prognostic Factors of Biliary Mixed Neuroendocrine Nonneuroendocrine Neoplasms

Pooled analysis of ampullary mixed neuroendocrine-non-neuroendocrine neoplasm

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives

Current Treatment Status In Pancreatic Neuroendocrine Neoplasms

Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors